Series date: 
01/01/2024 - 7:00am CST to 12/31/2024 - 8:00am CST

Accreditation

HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
  • Credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program
  • 1.00 MOC Lifelong Learning point in the American Board of Pathology (ABPath) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC or ABS and ABPath credit.

Objectives

Regularly attending this series will allow participants to be able to:

  • Evaluate and discuss complications of biologic therapies to patient management
  • Design strategies that incorporate the most recent evidence-based data to effectively treat patients with IBD 
  • Assess the role roles and responsibilities of the multidisciplinary care team

Target Audience

This regularly scheduled series is intended for our internal audience by invitation.

Series location: 
Methodist Hospital
St. Louis Park, MN 55426
United States

Sessions

Session Date
IBD Case Conference 05/09/2024 - 7:00am to 8:00am CDT
IBD Case Conference 10/10/2024 - 7:00am to 8:00am CDT
IBD Case Conference 12/12/2024 - 7:00am to 8:00am CST